Healthcare Contract Research Organization Market to Grow at a CAGR of 6.8% During 2020-2025
Increased Focus on Drug Development for Rare Diseases Driving the Growth of Healthcare Contract Research Organization Market.
BriefingWire.com, 1/11/2021 - Healthcare Contract Research Organization Market size is estimated to be $38 billion in 2019, growing at a CAGR of 6.8% during the forecast period 2020-2025. Healthcare Contract Research Organization is independent organizations outsourced by other companies in order to perform research which includes pre-clinical to post clinical stages depending on the company requirements. The major revenue source of CROs comes from the Research and development budget of the sponsor companies majorly from Pharma and Biotech sector. The wide source of revenue comes from biopharmaceutical firms, in recent years owing to more R&D scrutiny and patent expiration on drug discovery has resulted into more reliability towards outsourcing. CRO market outsourcing in the pharmaceutical sector is driven by their expertise which is lacked by the in house team, increased global reach, high quality, risk mitigation, cost saving in capital investment and access to innovation. The R&D spending by pharmaceuticals have increased for rare disease for which there is a large scope for discovery has also boosted the market growth. CRO services are segmented into- early stage development services m(pre-clinical and clinical pharmacology) and late stage development services (clinical trials and central laboratory services). CRO outsourcing service have increased for Clinical Data Management, Biostatistics and Pharmacovigilance and drug discovery service is the most important driver for the market globally.